Wassim Abida

Also affiliated with Kettering University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.064

Top 100%

0DataRank

Top 100%0 citations

Samantha E. Vasselman, Ethan Barnett, Barbara Nweji, Emily Carbone, Alexander Blum +10 more

Papers

Driven by 26 papers — median percentile 0. Top paper: “Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients”.

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine(2017)10.1038/nm.4333

N/A

1.2DataRank · unranked

3490 citations

Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R. Kim +116 more

Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers

Investigational New Drugs(2021)10.1007/s10637-020-01035-9

N/A

1.2DataRank · unranked

32 citations

D. Liu, Michael Offin, Cecilia Lezcano, Jean Torrisi, Sheldon L. Brownstein +13 more

AKT mutant allele-specific activation dictates pharmacologic sensitivities

Nature Communications(2022)10.1038/s41467-022-29638-1

N/A

1.2DataRank · unranked

36 citations

Tambudzai Shamu, Alexander N. Gorelick, Matthew T. Chang, Debyani Chakravarty, Elena I. Gavrila +14 more

Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

Cell(2022)10.1016/j.cell.2022.01.003

N/A

0.973DataRank · unranked

654 citations

Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar +70 more

Regenerative potential of prostate luminal cells revealed by single-cell analysis

Science(2020)10.1126/science.aay0267

N/A

0.859DataRank · unranked

306 citations

Matan Hofree, Danielle Choi, Eliot L. Linton, Mesruh Turkekul, Alborz Bejnood +16 more

Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS

Nature Communications(2021)10.1038/s41467-021-24109-5

N/A

0.782DataRank · unranked

183 citations

Gowtham Jayakumaran, Monica Diosdado, Juber Patel, Anna Razumova, Yu Hu +64 more

Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Genome Medicine(2021)10.1186/s13073-021-00898-8

N/A

0.614DataRank · unranked

59 citations

Michael L. Cheng, Maha Shady, Julie L. Yang, Dennis Stephens, Helen Won +32 more

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.064

Top 100%

0DataRank

Top 100%0 citations

Samantha E. Vasselman, Ethan Barnett, Barbara Nweji, Emily Carbone, Alexander Blum +10 more

Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer

Journal of Immunotherapy and Precision Oncology(2023)10.36401/jipo-23-9

N/A

0DataRank · unranked

5 citations

Justine Anderson, Daniel C. Danila, Michael J. Morris, Susan F. Slovin, Wassim Abida +5 more

Data from Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors

(2023)10.1158/1078-0432.c.6530694

N/A

0DataRank · unranked

0 citations

Nabeela Khan Patail, Rahim Hirani, Subhiksha Nandakumar, Ying Z. Mazzu, Yuki Yoshikawa +10 more

Data from Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2-altered Prostate Tumors

(2023)10.1158/1078-0432.c.6530694.v1

N/A

0DataRank · unranked

0 citations

Nabeela Khan Patail, Rahim Hirani, Subhiksha Nandakumar, Ying Z. Mazzu, Yuki Yoshikawa +10 more

A multi-center natural history study of precision-based genomics in prostate cancer (PC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps5121

N/A

0DataRank · unranked

0 citations

Joaquı́n Mateo, Wassim Abida, Rana R. McKay, Bruce Montgomery, Rahul Aggarwal +5 more

Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3403

N/A

0DataRank · unranked

54 citations

Vignesh Ravichandran, Samantha Brown, Syed M. Alam, Andrew Katims, Hong Truong +25 more

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0400

N/A

0DataRank · unranked

34 citations

Melissa A. Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y. Feng +17 more

RAD21 promotes oncogenesis and lethal progression of prostate cancer

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2405543121

N/A

0DataRank · unranked

9 citations

Konrad H. Stopsack, Daniel R. Schmidt, Duanduan Ma, Zhe Li, Paul Scheet +13 more

Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer

European Urology Oncology(2024)10.1016/j.euo.2024.11.011

N/A

0DataRank · unranked

8 citations

Wassim Abida, Emmanuel S. Antonarakis, Alan H. Bryce, Elena Castro, Heather H. Cheng +3 more

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

UNC Libraries(2024)10.17615/6gs3-hm85

N/A

0DataRank · unranked

0 citations

Irina Ostrovnaya, Matthew I. Milowsky, Jonathan E. Rosenberg, Wassim Abida, Dean F. Bajorin +6 more

BRCA2 reversion mutation–independent resistance to PARP inhibition through impaired DNA prereplication complex function

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2426743122

N/A

0DataRank · unranked

10 citations

Matteo Ferrari, Perianne Smith, Subhiksha Nandakumar, Zahra Khan, Serina B Young +9 more

Symptomatic Prostate-Specific Membrane Antigen PET–Positive Radionecrosis After Multimodality Brain Metastasis–Directed Treatment Including [177Lu]Lu-PSMA-617

Journal of Nuclear Medicine(2025)10.2967/jnumed.124.269175

N/A

0DataRank · unranked

1 citations

Kenny Yu, Wassim Abida, Luke Pike, Milan Grkovski, Thomas Kaley +10 more

BRCA2 reversion mutation-independent resistance to PARP inhibition in prostate cancer through loss of function perturbations in the DNA pre-replication complex

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.04.20.649668

N/A

0DataRank · unranked

1 citations

Matteo Ferrari, Perianne Smith, Subhiksha Nandakumar, Zahra Khan, Serina B Young +9 more

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation

Cancer Cell(2020)10.1016/j.ccell.2020.03.001

N/A

0DataRank · unranked

166 citations

Chuanli Zhou, Xiaoling Li, Spencer Barnes, Su Deng, Elizabeth Hoover +27 more

Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer

Cancer Cell(2020)10.1016/j.ccell.2020.06.005

N/A

0DataRank · unranked

256 citations

Wouter R. Karthaus, Young Sun Lee, Vianne R. Gao, Chao Wu, Joshua W. Russo +24 more

Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis

Cancer Discovery(2020)10.1158/2159-8290.cd-19-1242

N/A

0DataRank · unranked

61 citations

Marcus Ruscetti, Zhen Cao, Yu-Jui Ho, Timour Baslan, Min Zou +20 more

Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in BRCA2 -altered Prostate Tumors

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2483

N/A

0DataRank · unranked

21 citations

Nabeela Khan Patail, Rahim Hirani, Subhiksha Nandakumar, Ying Z. Mazzu, Yuki Yoshikawa +10 more

Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5022

N/A

0DataRank · unranked

1 citations

Kelsey Breen, Yelena Kemel, Andrew T. Lenis, Peter A. Reisz, Nicole Benfante +15 more

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

Nature Communications(2022)10.1038/s41467-022-30496-0

N/A

0DataRank · unranked

194 citations

Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis +38 more

Wassim Abida

Indexed papers

Top data-sharing exemplar

Papers